Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease
Authors
Keywords
Alzheimer’s disease, Mild cognitive impairment, Cerebrospinal fluid, Biomarker, Inflammation, Discriminative power
Journal
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-27
DOI
10.1186/s13195-018-0353-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
- (2017) Yuho Okita et al. Frontiers in Neuroscience
- Evaluation of Intrathecal Serum Amyloid P (SAP) and C-Reactive Protein (CRP) Synthesis in Alzheimer's Disease with the Use of Index Values
- (2017) Sandra D. Mulder et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
- (2016) Juan Domingo Gispert et al. Alzheimers & Dementia
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- The ASA's Statement onp-Values: Context, Process, and Purpose
- (2016) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
- (2016) Aaron D. Gitler et al. BRAIN RESEARCH
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Targeting microglia for the treatment of Alzheimer's Disease
- (2016) Paul D. Wes et al. GLIA
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias
- (2016) Aiqing Chen et al. NEUROBIOLOGY OF AGING
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- GWAS of longitudinal amyloid accumulation on18F-florbetapir PET in Alzheimer’s disease implicates microglial activation geneIL1RAP
- (2015) Vijay K Ramanan et al. BRAIN
- Sensitivity, Specificity, PPV, and NPV for Predictive Biomarkers
- (2015) Richard Simon JNCI-Journal of the National Cancer Institute
- TREM2 in CNS homeostasis and neurodegenerative disease
- (2015) Meghan M. Painter et al. Molecular Neurodegeneration
- Innate immunity in Alzheimer's disease
- (2015) Michael T Heneka et al. NATURE IMMUNOLOGY
- TREM2 variants and risk of Alzheimer’s disease: a meta-analysis
- (2015) Yanjun Lu et al. NEUROLOGICAL SCIENCES
- Monomeric C-reactive protein-a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?
- (2015) M. Slevin et al. Scientific Reports
- Sensitivity, Specificity, PPV, and NPV for Predictive Biomarkers
- (2015) Richard Simon JNCI-Journal of the National Cancer Institute
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
- (2014) Frederic Brosseron et al. MOLECULAR NEUROBIOLOGY
- Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias
- (2014) Gary W. Beecham et al. PLoS Genetics
- Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation
- (2014) John S. K. Kauwe et al. PLoS Genetics
- Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment
- (2013) Daniel Lindqvist et al. BRAIN BEHAVIOR AND IMMUNITY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- What does complement do in Alzheimer’s disease? Old molecules with new insights
- (2013) Yong Shen et al. Translational Neurodegeneration
- Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women
- (2012) Alex P. Reiner et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mrp14 Deficiency Ameliorates Amyloid Burden by Increasing Microglial Phagocytosis and Modulation of Amyloid Precursor Protein Processing
- (2012) M. P. Kummer et al. JOURNAL OF NEUROSCIENCE
- The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
- (2012) A. Koyama et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Amyloid Plaques Dissociate Pentameric to Monomeric C-Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease?
- (2011) Frederik Strang et al. BRAIN PATHOLOGY
- CRP gene variation affects early development of Alzheimer's disease-related plaques
- (2011) Eloise Kok et al. Journal of Neuroinflammation
- Biomarkers: Portents of malignancy
- (2011) Vicki Brower NATURE
- Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer’s disease
- (2011) Bing-Tian Bi et al. NEUROCHEMISTRY INTERNATIONAL
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample
- (2010) Jaroslav A. Hubacek et al. HUMAN IMMUNOLOGY
- Inflammatory markers in AD and MCI patients with different biomarker profiles
- (2008) Alie Schuitemaker et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started